Extreme body mass index and survival in newly diagnosed multiple myeloma patients Correspondence

   

Authors:	Shah, U. A.; Whiting, K.; Devlin, S.; Ershler, R.; Kanapuru, B.; Lee, D. J.; Tahri, S.; Gwise, T.; Rustad, E. H.; Mailankody, S.; Lesokhin, A. M.; Kazandjian, D.; Maura, F.; Auclair, D.; Birmann, B. M.; Usmani, S. Z.; Gormley, N.; Marinac, C. R.; Landgren, O.
Title:	Extreme body mass index and survival in newly diagnosed multiple myeloma patients
Keywords:	adult; treatment outcome; aged; survival rate; major clinical study; overall survival; mortality; follow up; letter; progression free survival; bortezomib; multiple myeloma; obesity; cytogenetics; autologous stem cell transplantation; body mass; body mass index; adverse outcome; underweight; descriptive research; body weight loss; international staging system; charlson comorbidity index; humans; human; male; female; ecog performance status; obese patient
Journal Title:	Blood Cancer Journal
Volume:	13
ISSN:	2044-5385
Publisher:	Nature Publishing Group
Date Published:	2023-01-12
Start Page:	13
Language:	English
DOI:	10.1038/s41408-022-00782-7
PUBMED:	36631444
PROVIDER:	scopus
PMCID:	PMC9834289
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85146133878&doi=10.1038%2fs41408-022-00782-7&partnerID=40&md5=a5256b40b6120ec37c8aa23ddb37bec2
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PDF -- Corresponding author is MSK author: Urvi A. Shah -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/202507